Benzinga's Volume Movers

shares climbed 7.39 percent to $50.84. The volume of Nevro shares traded was 937 percent higher than normal. Nevro reported better-than-expected Q3 results.

shares rose 16.29 percent to $19.49. The volume of Bellicum Pharmaceuticals shares traded was 747 percent higher than normal. For the third quarter of 2015, the company reported a net loss of $13.4 million, compared to a net loss of $4.1 million reported a year ago.

surged 29.89 percent to $10.38. The volume of SciClone Pharmaceuticals shares traded was 635 percent higher than normal. SciClone Pharmaceuticals reported Q3 adjusted earnings of $0.26 per share on revenue of $42.9 million.

shares moved up 2.38 percent to $39.19. The volume of Lions Gate traded was 552 percent higher than normal. Lions Gate reported weaker-than-expected results for its second quarter on Monday.

and

would each take a 3.4 percent stake in LionsGate.